title: Coronary embolization in hypertrophic cardiomyopathy with left ventricular apical aneurysm.
abstract: Patients with left ventricular apical aneurysms represent a unique patient subgroup in the broad clinical spectrum of hypertrophic cardiomyopathy (HC) associated with the risk for sudden death, heart failure, and peripheral thromboembolism. Routine chronic anticoagulation has not been a standard recommendation for these patients. We present a 36-year-old patient with HC with features of acute coronary syndrome, likely secondary to coronary thromboembolism as a complication of left ventricular apical aneurysm. Our experience with this patient raises consideration for prophylactic anticoagulant therapy for this unusual subset of patients with HC.
authors.affiliation: The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota.
authors.forename: Ankur
authors.initials: A
authors.lastname: Kalra
authors.affiliation: Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
authors.forename: Martin S
authors.initials: MS
authors.lastname: Maron
authors.affiliation: Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
authors.forename: Ethan J
authors.initials: EJ
authors.lastname: Rowin
authors.affiliation: Advanced Cardiovascular Specialists LLP, Beaumont, Texas.
authors.forename: Timothy K
authors.initials: TK
authors.lastname: Colgan
authors.affiliation: The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota.
authors.forename: John R
authors.initials: JR
authors.lastname: Lesser
authors.affiliation: The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota. Electronic address: hcm.maron@mhif.org.
authors.forename: Barry J
authors.initials: BJ
authors.lastname: Maron
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications*; D004621:Embolization, Therapeutic; D006322:Heart Aneurysm / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D013923:Thromboembolism / Q000517:prevention & control
chemical_list: D000925:Anticoagulants